Infection Control & Hospital Epidemiology
Conflicts of interest. All authors declare no conflicts of interest relevant to this article.
923
Cleaning for Prevention and Control of Infections in All Health Care Settings, 2nd revision. Toronto, Canada; 2012.
17. Surface Sampling Procedures for Bacillus Anthracis Spores from Smooth, Non-Porous Surfaces. Washington, USA: The National Institute for Occupational Safety and Health; 2012.
References
1. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881–891.
2. Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primer 2016;2:16020.
3. Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. Clostridium difficile infection following systemic antibiotic administration in rando- mised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents 2016;48:1–10.
4. Kramer A, Schwebke I, Kampf
G.How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:130.
5. Sethi AK, Al‐Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010;31:21–27.
6. SamoreMH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32–40.
7. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010;38:S25–S33.
8. Hospodsky D, Yamamoto N, Peccia J. Accuracy, precision, and method detection limits of quantitative PCR for airborne bacteria and fungi. Appl Environ Microbiol 2010;76:7004–7012.
9. Shams AM, Rose LJ, Edwards JR, et al. Assessment of the overall and multidrug-resistant organism bioburden on environmental surfaces in healthcare facilities. Infect Control Hosp Epidemiol 2016;37:1426–1432.
10. Ali S, Muzslay M, Wilson P. A novel quantitative sampling technique for detection and monitoring of Clostridium difficile contamination in the clinical environment. J Clin Microbiol 2015;53:2570–2574.
11. Engelhardt NEP, Foster NF, Hong S, Riley TV, McGechie DB. Comparison of two environmental sampling tools for the detection of Clostridium difficile spores on hard bathroom surfaces in the hospital setting. J Hosp Infect 2017;96:295–296.
12. Huslage K, Rutala WA, Sickbert-Bennett E, Weber DJ. A quantitative approach to defining “high-touch” surfaces in hospitals. Infect Control Hosp Epidemiol 2010;31:850–853.
13. Rashid T, Vonville H, Hasan I, Garey KW. Mechanisms for floor surfaces or environmental ground contamination to cause human infection: a systematic review. Epidemiol Infect 2017;145:347–357.
14. Altman N, Krzywinski M. Points of significance: split plot design. Nat Methods 2015;12:165–166.
15. Jones B, Nachtsheim CJ. Split-plot designs: what, why, and how. J Qual Technol 2009;41:340–361.
16. Ontario Agency for Health Protection and Promotion, Provincial Infectious Diseases Advisory Committee. Best Practices for Environmental
18. Mutters R, Nonnenmacher C, Susin C, Albrecht U, Kropatsch R, Schumacher S. Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction. J Hosp Infect 2009;71:43–48.
19. Kilic A, Alam MJ, Tisdel NL, et al. Multiplex real-time PCR method for simultaneous identification and toxigenic type characterization of Clostridium difficile from stool samples. Ann Lab Med 2015;35:306.
20. Ogden TL. Handling results below the level of detection. Ann Occup Hyg 2010;54:255–256.
21. Hidalgo B, Goodman M. Multivariate or multivariable regression? Am J Public Health 2013;103:39–40.
22. Guthrie KA, Gammill HS, Kamper-Jørgensen M, et al. Statistical methods for unusual count data: examples from studies of microchimerism. Am J Epidemiol 2016;184:779–786.
23. Stan Development Team. rstanarm: Bayesian applied regression modeling via Stan. R package version 2.13.1. Stan website.
http://mc-stan.org/. Published 2016. Accessed April 23, 2018.
24. Buggy BP, Wilson KH, Fekety R. Comparison of methods for recovery of Clostridium difficile from an environmental surface. J Clin Microbiol 1983;18:348–352.
25. Nerandzic MM, Donskey CJ. Effective and reduced-cost modified selective medium for isolation of Clostridium difficile. J Clin Microbiol 2009;47:397–400.
26. Buttner MP, Cruz P, Stetzenbach LD, Klima-Comba AK, Stevens VL, Emanuel PA. Evaluation of the biological sampling kit (BiSKit) for large- area surface sampling. Appl Environ Microbiol 2004;70:7040–7045.
27. Moore G, Muzslay M, Wilson APR. The type, level, and distribution of microorganisms within the ward environment: a zonal analysis of an intensive care unit and a gastrointestinal surgical ward. Infect Control Hosp Epidemiol 2013;34:500–506.
28. Rashid T, VonVille HM, Hasan I, Garey KW. Shoe soles as a potential vector for pathogen transmission: a systematic review. J Appl Microbiol 2016;121:1223–1231.
29. Qian J, Peccia J, Ferro AR. Walking-induced particle resuspension in indoor environments. Atmos Environ 2014;89:464–481.
30. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015;175:626–633.
31. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile–associated disease pressure as a risk factor for C difficile– associated disease. Arch Intern Med 2007;167:1092–1097.
32. Tosas Auguet O, Stabler RA, Betley J, et al. Frequent undetected ward- based methicillin-resistant Staphylococcus aureus transmission linked to patient sharing between hospitals. Clin Infect Dis 2018;66:840–848.
33. Weese JS. Clostridium difficile in food–innocent bystander or serious threat? Clin Microbiol Infect 2010;16:3–10.
34. Lawley TD, Clare S, Deakin LJ, et al. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 2010;76:6895–6900.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140
